Advanced Medical Solutions Group plc (FRA:AQA)

Market Cap	518.86M
Revenue (ttm)	257.01M
Net Income (ttm)	10.64M
Shares Out	n/a
EPS (ttm)	0.05
PE Ratio	48.75
Forward PE	15.91
Dividend	0.03 (1.29%)
Ex-Dividend Date	Sep 25, 2025

Volume	n/a
Average Volume	5
Open	2.420
Previous Close	2.340
Day's Range	2.420 - 2.420
52-Week Range	2.040 - 2.780
Beta	n/a
RSI	53.81
Earnings Date	Dec 16, 2025

About FRA:AQA

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and Acti...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1991
• Employees: 1,600
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AQA

Financial Performance

In 2024, FRA:AQA's revenue was 177.52 million, an increase of 40.66% compared to the previous year's 126.21 million. Earnings were 7.09 million, a decrease of -55.35%.

Financial numbers in GBP